Obstet Gynecol Sci.  2022 Mar;65(2):105-112. 10.5468/ogs.22900.

Informed consent forms for gynecologic cancer surgery: recommendations from the Korean Society of Gynecologic Oncology

• Chang HK
• Shim SH
• Lee M
• Lee WM
• Eoh KJ
• Yoo HJ
• Kim MK
• Kim MK
• Lee KB
• So KA
• Kim YT
• Lee DW
• Hyun DY
• Lee JM

• KMID: 2527262
• DOI: http://doi.org/10.5468/ogs.22900

Abstract

The sociomedical environment is changing. In the traditional physician-patient relationship, the physician was authoritative and the patient was obedient. The contractual relationship featured patient consent to the physician’s decision. Today, the physician must explain fully the planned medical treatment, and any alternative, to the patient, who has the right to choose her treatment after considering the benefits and side-effects. The Korean Society of Gynecologic Oncology thus decided to standardize the surgical consent forms to meet the legal requirements of modern medicine, improve patient understanding of the surgical details, and protect medical staff from legal disputes. To determine the format and content, subcommittees for each cancer type collected and reviewed all relevant articles and the current consent forms of domestic medical institutions. After several meetings, 16 basic items to be included for each type of gynecologic cancer were selected. Also, to help patients understand the surgical details, figures were included. The revised forms were legally reviewed in terms of the appropriateness of the format and content. We also developed English versions to provide adequate information for foreign patients. We hope that these efforts will promote trust between patients and physicians, and contribute to effective treatment by laying a foundation of mutual respect.

Keyword

Informed consent; Gynecologic neoplasm; Gynecologic surgery; Medical ethics; Clinical practice pattern

Reference

References

1. Stain SC. Informed surgical consent. J Am Coll Surg. 2016; 222:717–8.

2. Korea Medical Dispute Mediation and Arbitration Agency. Medical dispute mediation and arbitration statistical yearbook 2020 [Internet]. Seoul (KR): Korea Medical Dispute Mediation and Arbitration Agency;c2021. [cited 2021 Jun 4]. Available from: https://www.k-medi.or.kr/lay1/bbs/S1T27C96/A/25/list.do .

3. Cocanour CS. Informed consent-It’s more than a signature on a piece of paper. Am J Surg. 2017; 214:993–7.

4. Leclercq WK, Keulers BJ, Scheltinga MR, Spauwen PH, van der Wilt GJ. A review of surgical informed consent: past, present, and future. A quest to help patients make better decisions. World J Surg. 2010; 34:1406–15.

5. Sarela AI, Thomson M. Balancing law, ethics and reality in informed consent for surgery. Ann R Coll Surg Engl. 2014; 96:329–30.

6. Korea Health Industry Development Institute. Statistics on international patients in Korea 2018 [Internet]. Cheongju (KR): Korea Health Industry Development Institute;c2021. [cited 2021 Jun 4]. Available from: https://www.khidi.or.kr/board/view?linkId=48806593&menuId=MENU00085 .

7. Korea Ministry of Government Legislation. Medical Service Act [Internet]. Sejong (KR): Korea Legislation Research Institute;c2021. [cited 2021 Jun 4]. Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=53532&lang=ENG .

8. Fair Trade Commission. [No. 10003] Standard terms of consent (surgery, procedure, test, anesthesia, sedation of consciousness) [Internet]. Sejong (KR): Fair Trade Commission;c2021. [cited 2021 Jun 4]. Available from: https://www.ftc.go.kr/www/cop/bbs/selectBoardArticle.do?key=201&nttId=82483&bbsId=BBSMSTR_000000002320&bbsTyCode=BBST01 .

9. Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017; 118:317–34.

10. Assaad S, Kratzert WB, Shelley B, Friedman MB, Perrino A Jr. Assessment of pulmonary edema: principles and practice. J Cardiothorac Vasc Anesth. 2018; 32:901–14.

11. Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines as mediators of fever. Clin Infect Dis. 2000; 31(Suppl 5):S178–84.

12. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg. 2003; 73:144–53.

13. Golden D, Corbett J, Forni LG. Peri-operative renal dysfunction: prevention and management. Anaesthesia. 2016; 71(Suppl 1):51–7.

14. Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018; 2:3226–56.

15. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999; 340:1154–61.

16. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340:1137–43.

17. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018; 379:1895–904.

18. Kim M, Kong TW, Kim S, Kim SC, Kim YB, Kim JW, et al. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement. J Gynecol Oncol. 2019; 30:e104.

19. Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018; 379:1905–14.

20. Lee M, Choi CH, Chun YK, Kim YH, Lee KB, Lee SW, et al. Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy. J Gynecol Oncol. 2017; 28:e5.

21. Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008; 9:297–303.

22. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005; 106:413–25.

23. Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009; 27:1214–9.

24. Lee TS, Lee JY, Kim JW, Oh S, Seong SJ, Lee JM, et al. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol. 2013; 131:289–93.

25. Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, et al. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010; 119:291–4.

26. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010; 375:1165–72.

27. Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Jeffrey Lowery W, et al. Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol. 2017; 146:405–15.

28. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017; 18:384–92.

29. Barlin JN, Puri I, Bristow RE. Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol. 2010; 118:14–8.

30. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010; 363:943–53.

31. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006; 95(Suppl 1):S161–92.